Trade Summary

4 days ago, Cohen Yuval, serving as Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 17,000 shares at $10.08 per share, for a total transaction value of $171,395.70. Following this transaction, Cohen Yuval now holds 157,316 shares of CRBP.

This sale represents a 9.75% decrease in Cohen Yuval's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 4:30 PM ET, 3 days after the trade was made.

Corbus Pharmaceuticals Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.